Literature DB >> 24206773

Modulation of the stacking interaction of MN4 (M=Pt, Pd, Au) complexes with tryptophan through N-heterocyclic ligands.

Samantha D Tsotsoros1, Aaron B Bate1, Martina G Dows1, Sarah R Spell1, Craig A Bayse2, Nicholas P Farrell3.   

Abstract

A survey of selected N-heterocycle ligands showed that platination of 4-N-dimethylaminopyridine (DMAP) in [Pt(dien)L](2+) (dien=diethylenetriamine) gave especially strong π-π stacking interactions with tryptophan and the tryptophan-containing C-terminal zinc finger (ZF) of the HIV (human immunodeficiency virus) nucleocapsid protein NCp7. The association constants (all at 10(3)M(-1)) were significantly stronger (25.0 and 28.1 for tryptophan and ZF respectively) than those previously measured for the purine nucleobase 9-ethylguanine (9EtG) in [Pt(dien)(9EtG)](2+) (6.88 and 7.55 for tryptophan and ZF respectively). Extension to Pd and Au complexes also confirmed the utility of DMAP in assisting stacking interactions. The results confirm the utility of a "bioinorganic" approach to targeting and inactivation of medicinal chemistry targets using the dual approach of target recognition (non-covalent) followed by target fixation (covalent).
© 2013.

Entities:  

Keywords:  HIV NCp7 peptide; Platinum–metal heterocycle ligands; Tryptophan stacking

Mesh:

Substances:

Year:  2013        PMID: 24206773     DOI: 10.1016/j.jinorgbio.2013.09.020

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  2 in total

1.  Dinuclear platinum complexes containing planar aromatic ligands to enhance stacking interactions with proteins.

Authors:  Erin S F Ma; A Gerard Daniel; Nicholas P Farrell
Journal:  ChemMedChem       Date:  2014-05-06       Impact factor: 3.466

2.  Enhancement of the physicochemical properties of [Pt(dien)(nucleobase)]2+ for HIVNCp7 targeting.

Authors:  S D Tsotsoros; P B Lutz; A G Daniel; E J Peterson; R E F de Paiva; E Rivera; Y Qu; C A Bayse; N P Farrell
Journal:  Chem Sci       Date:  2016-10-06       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.